Philip M. Gammell

Associate Director of Engineering, Astellas Pharma Inc.

Pharmaceutical/Biopharma professional with extensive experience in a range of technical and managerial positions in Manufacturing, Validation, Technology Transfer and Engineering. Experience in both large molecule (vaccine manufacture) and small molecule (API, OSD & Sterile fill-finish) manufacturing operations. Currently a member of Astellas' Global Engineering and Innovation function, specialising in development and introduction of innovative technologies and Pharma 4.0. Vice- president of ISPE Ireland Affiliate and founder of ISPE Pharma 4IReland group to address the challenges of introducing Industry 4.0 to Pharma/Biopharma industry.